What they were paid
CRESCENT BIOPHARMA Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $30,041 | $0 | $106,923 | $0 | $136,964 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CRESCENT BIOPHARMA, INC. DEF 14A filed April 21, 2026, accession 0001628280-26-026282, and prior-year filings. Open the filing on EDGAR.
How this page was built: the CRESCENT BIOPHARMA, INC. filed document, accession 0001628280-26-026282. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2026.
Get the CRESCENT BIOPHARMA Board Governance Report
$136,964 Susan Moran, M.D., MSCE, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 21, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025CRESCENT BIOPHARMA pays directors a $40,000 cash retainer.
The rest of the CRESCENT BIOPHARMA board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alexandra Balcom | Independent Director | $140,466 |
| David Lubner | Independent Director | $294,991 |
| Jonathan Violin, Ph.D | Director | $474,301 |
| Joshua Brumm | Director | — |
| Peter Harwin | Independent Director | $151,575 |
The full CRESCENT BIOPHARMA compensation record
free company briefThis page is one director within CRESCENT BIOPHARMA's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the CRESCENT BIOPHARMA proxy · each links to its own free briefOrder CBIO
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.